New York, Sept. 10, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Biodefense Industry" - https://www.reportlinker.com/p05961247/?utm_source=GNW
5 Billion by 2027, growing at a CAGR of 5.4% over the period 2020-2027.Vaccines, one of the segments analyzed in the report, is projected to grow at a 5.6% CAGR to reach US$12.5 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Biothreat Detection Devices segment is readjusted to a revised 5.1% CAGR for the next 7-year period. This segment currently accounts for a 37.1% share of the global Biodefense market.
The U.S. Accounts for Over 29.5% of Global Market Size in 2020, While China is Forecast to Grow at a 5% CAGR for the Period of 2020-2027
The Biodefense market in the U.S. is estimated at US$4 Billion in the year 2020. The country currently accounts for a 29.48% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$3.4 Billion in the year 2027 trailing a CAGR of 5% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.2% and 4.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR while Rest of European market (as defined in the study) will reach US$3.4 Billion by the year 2027.We bring years of research experience to this 17th edition of our report. The 150-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
Competitors identified in this market include, among others,
- Achaogen, Inc.
- Alexeter Technologies, LLC
- Alnylam Pharmaceuticals, Inc.
- Altimmune, Inc.
- ANP Technologies, Inc.
- Bavarian Nordic A/S
- Cleveland BioLabs, Inc.
- Elusys Therapeutics, Inc.
- Emergent BioSolutions, Inc.
- Ichor Medical Systems, Inc.
- New Horizons Diagnostic Corporation
- PathSensors, Inc.
- Research International, Inc.
- SIGA Technologies
Read the full report: https://www.reportlinker.com/p05961247/?utm_source=GNW
I. INTRODUCTION, METHODOLOGY & REPORT SCOPE
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Impact of Covid-19 and a Looming Global Recession
Global Competitor Market Shares
Biodefense Competitor Market Share Scenario Worldwide (in %):
2018E
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Biodefense by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Billion for Years 2018 through 2027
Table 2: World Historic Review for Biodefense by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Billion for Years 2012 through 2017
Table 3: World 15-Year Perspective for Biodefense by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets
for Years 2012, 2018 & 2027
Table 4: World Current & Future Analysis for Vaccines by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Billion for Years 2018 through 2027
Table 5: World Historic Review for Vaccines by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Billion for Years 2012 through 2017
Table 6: World 15-Year Perspective for Vaccines by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2018 & 2027
Table 7: World Current & Future Analysis for Biothreat
Detection Devices by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2018 through 2027
Table 8: World Historic Review for Biothreat Detection Devices
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Billion for Years 2012 through 2017
Table 9: World 15-Year Perspective for Biothreat Detection
Devices by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2012, 2018 & 2027
III. MARKET ANALYSIS
GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Biodefense Market Share (in %) by Company: 2018 & 2027
Market Analytics
Table 10: USA Current & Future Analysis for Biodefense by
Product - Vaccines and Biothreat Detection Devices -
Independent Analysis of Annual Sales in US$ Billion for the
Years 2018 through 2027
Table 11: USA Historic Review for Biodefense by Product -
Vaccines and Biothreat Detection Devices Markets - Independent
Analysis of Annual Sales in US$ Billion for Years 2012 through
2017
Table 12: USA 15-Year Perspective for Biodefense by Product -
Percentage Breakdown of Value Sales for Vaccines and Biothreat
Detection Devices for the Years 2012, 2018 & 2027
CANADA
Table 13: Canada Current & Future Analysis for Biodefense by
Product - Vaccines and Biothreat Detection Devices -
Independent Analysis of Annual Sales in US$ Billion for the
Years 2018 through 2027
Table 14: Canada Historic Review for Biodefense by Product -
Vaccines and Biothreat Detection Devices Markets - Independent
Analysis of Annual Sales in US$ Billion for Years 2012 through
2017
Table 15: Canada 15-Year Perspective for Biodefense by Product -
Percentage Breakdown of Value Sales for Vaccines and
Biothreat Detection Devices for the Years 2012, 2018 & 2027
JAPAN
Table 16: Japan Current & Future Analysis for Biodefense by
Product - Vaccines and Biothreat Detection Devices -
Independent Analysis of Annual Sales in US$ Billion for the
Years 2018 through 2027
Table 17: Japan Historic Review for Biodefense by Product -
Vaccines and Biothreat Detection Devices Markets - Independent
Analysis of Annual Sales in US$ Billion for Years 2012 through
2017
Table 18: Japan 15-Year Perspective for Biodefense by Product -
Percentage Breakdown of Value Sales for Vaccines and Biothreat
Detection Devices for the Years 2012, 2018 & 2027
CHINA
Table 19: China Current & Future Analysis for Biodefense by
Product - Vaccines and Biothreat Detection Devices -
Independent Analysis of Annual Sales in US$ Billion for the
Years 2018 through 2027
Table 20: China Historic Review for Biodefense by Product -
Vaccines and Biothreat Detection Devices Markets - Independent
Analysis of Annual Sales in US$ Billion for Years 2012 through
2017
Table 21: China 15-Year Perspective for Biodefense by Product -
Percentage Breakdown of Value Sales for Vaccines and Biothreat
Detection Devices for the Years 2012, 2018 & 2027
EUROPE
Market Facts & Figures
European Biodefense Market: Competitor Market Share Scenario:
(in %) for 2018 & 2027
Market Analytics
Table 22: Europe Current & Future Analysis for Biodefense by
Geographic Region - France, Germany, Italy, UK and Rest of
Europe Markets - Independent Analysis of Annual Sales in US$
Billion for Years 2018 through 2027
Table 23: Europe Historic Review for Biodefense by Geographic
Region - France, Germany, Italy, UK and Rest of Europe Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2012 through 2017
Table 24: Europe 15-Year Perspective for Biodefense by
Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK and Rest of Europe Markets for Years
2012, 2018 & 2027
Table 25: Europe Current & Future Analysis for Biodefense by
Product - Vaccines and Biothreat Detection Devices -
Independent Analysis of Annual Sales in US$ Billion for the
Years 2018 through 2027
Table 26: Europe Historic Review for Biodefense by Product -
Vaccines and Biothreat Detection Devices Markets - Independent
Analysis of Annual Sales in US$ Billion for Years 2012 through
2017
Table 27: Europe 15-Year Perspective for Biodefense by Product -
Percentage Breakdown of Value Sales for Vaccines and
Biothreat Detection Devices for the Years 2012, 2018 & 2027
FRANCE
Table 28: France Current & Future Analysis for Biodefense by
Product - Vaccines and Biothreat Detection Devices -
Independent Analysis of Annual Sales in US$ Billion for the
Years 2018 through 2027
Table 29: France Historic Review for Biodefense by Product -
Vaccines and Biothreat Detection Devices Markets - Independent
Analysis of Annual Sales in US$ Billion for Years 2012 through
2017
Table 30: France 15-Year Perspective for Biodefense by Product -
Percentage Breakdown of Value Sales for Vaccines and
Biothreat Detection Devices for the Years 2012, 2018 & 2027
GERMANY
Table 31: Germany Current & Future Analysis for Biodefense by
Product - Vaccines and Biothreat Detection Devices -
Independent Analysis of Annual Sales in US$ Billion for the
Years 2018 through 2027
Table 32: Germany Historic Review for Biodefense by Product -
Vaccines and Biothreat Detection Devices Markets - Independent
Analysis of Annual Sales in US$ Billion for Years 2012 through
2017
Table 33: Germany 15-Year Perspective for Biodefense by Product -
Percentage Breakdown of Value Sales for Vaccines and
Biothreat Detection Devices for the Years 2012, 2018 & 2027
ITALY
Table 34: Italy Current & Future Analysis for Biodefense by
Product - Vaccines and Biothreat Detection Devices -
Independent Analysis of Annual Sales in US$ Billion for the
Years 2018 through 2027
Table 35: Italy Historic Review for Biodefense by Product -
Vaccines and Biothreat Detection Devices Markets - Independent
Analysis of Annual Sales in US$ Billion for Years 2012 through
2017
Table 36: Italy 15-Year Perspective for Biodefense by Product -
Percentage Breakdown of Value Sales for Vaccines and Biothreat
Detection Devices for the Years 2012, 2018 & 2027
UNITED KINGDOM
Table 37: UK Current & Future Analysis for Biodefense by
Product - Vaccines and Biothreat Detection Devices -
Independent Analysis of Annual Sales in US$ Billion for the
Years 2018 through 2027
Table 38: UK Historic Review for Biodefense by Product -
Vaccines and Biothreat Detection Devices Markets - Independent
Analysis of Annual Sales in US$ Billion for Years 2012 through
2017
Table 39: UK 15-Year Perspective for Biodefense by Product -
Percentage Breakdown of Value Sales for Vaccines and Biothreat
Detection Devices for the Years 2012, 2018 & 2027
REST OF EUROPE
Table 40: Rest of Europe Current & Future Analysis for
Biodefense by Product - Vaccines and Biothreat Detection
Devices - Independent Analysis of Annual Sales in US$ Billion
for the Years 2018 through 2027
Table 41: Rest of Europe Historic Review for Biodefense by
Product - Vaccines and Biothreat Detection Devices Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2012 through 2017
Table 42: Rest of Europe 15-Year Perspective for Biodefense by
Product - Percentage Breakdown of Value Sales for Vaccines and
Biothreat Detection Devices for the Years 2012, 2018 & 2027
ASIA-PACIFIC
Table 43: Asia-Pacific Current & Future Analysis for Biodefense
by Product - Vaccines and Biothreat Detection Devices -
Independent Analysis of Annual Sales in US$ Billion for the
Years 2018 through 2027
Table 44: Asia-Pacific Historic Review for Biodefense by
Product - Vaccines and Biothreat Detection Devices Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2012 through 2017
Table 45: Asia-Pacific 15-Year Perspective for Biodefense by
Product - Percentage Breakdown of Value Sales for Vaccines and
Biothreat Detection Devices for the Years 2012, 2018 & 2027
REST OF WORLD
Table 46: Rest of World Current & Future Analysis for
Biodefense by Product - Vaccines and Biothreat Detection
Devices - Independent Analysis of Annual Sales in US$ Billion
for the Years 2018 through 2027
Table 47: Rest of World Historic Review for Biodefense by
Product - Vaccines and Biothreat Detection Devices Markets -
Independent Analysis of Annual Sales in US$ Billion for Years
2012 through 2017
Table 48: Rest of World 15-Year Perspective for Biodefense by
Product - Percentage Breakdown of Value Sales for Vaccines and
Biothreat Detection Devices for the Years 2012, 2018 & 2027
IV. COMPETITION
Total Companies Profiled: 54
Read the full report: https://www.reportlinker.com/p05961247/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________